GC25638
Miransertib HCl
Also listed as Miransertib (ARQ 092) HCl
Miransertib (ARQ 092) HCl is a novel, orally bioavailable and selective AKT pathway inhibitor exhibiting a manageable safety profile among patients with advanced solid tumors
ChemicalCAS1313883-00-9MW468.98FormulaC27H25ClN6
- CAS number
- 1313883-00-9
- Molecular weight
- 468.98
- Formula
- C27H25ClN6
- Solubility
- DMSO： 75 mg/mL (159·92 mM);Water： Insoluble;Ethanol： 4 mg/mL (8·53 mM)
- InChIKey
- DRHSWSSVIKDJME-UHFFFAOYSA-N
- Catalogue number
- GC25638
- Brand
- GLPBIO
Computed properties PubChem CID 67305743 · TPSA 95.6 Ų · H-bond donors 3 · H-bond acceptors 5
- TPSA
- 95.6 Ų
- H-bond donors
- 3
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 34
SMILES C1CC(C1)(C2=CC=C(C=C2)N3C4=C(C=CC(=N4)C5=CC=CC=C5)N=C3C6=C(N=CC=C6)N)N.Cl
Computed descriptors from PubChem (CID 67305743), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il